Arnatar Therapeutics

Arnatar Therapeutics is focused on advancing RNA therapies, specifically through antisense oligonucleotides to target genetic disorders such as Alagille syndrome

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Arnatar Therapeutics is focused on advancing RNA therapies, specifically through antisense oligonucleotides to target genetic disorders such as Alagille syndrome.

02Backed By1 investor

GVGaorong Ventures→

03Similar Companies